HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia

Infectious Agents and Cancer

Volumn 8, Issue 1, 2013, Pages

  Alsbeih, Ghazi ^a   Al Harbi, Najla ^a   El Sebaie, Medhat ^a   Al Badawi, Ismail ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Cervical cancer; Human papillomavirus (HPV); Predisposition; Single nucleotide polymorphism (SNP)

Indexed keywords

ATM PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN E; PROTEIN BAX; PROTEIN MDM2; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1; XRCC1 PROTEIN; XRCC3 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRANDED DNA BREAK; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 84876985571     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-8-15     Document Type: Article

References (41)

1. Global cancer statistics, 2002. Parkin DM, Bray F, Ferlay J, Pisani P, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078 (Pubitemid 40372904)
2. Cancer Incidence and Mortality Worldwide, IARC CancerBase No. 10 [Internet] Available from: http://globocan.iarc.fr
3. Human papillomaviruses in the pathogenesis of anogenital cancer. Zur Hausen H, Virology 1991 184 9 13 10.1016/0042-6822(91)90816-T 1651607
4. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, J Natl Cancer Inst 1995 87 796 802 10.1093/jnci/87.11.796 7791229
5. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N, J Pathol 1999 189 12 19 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10451482 (Pubitemid 29406813)
6. Epidemiologic classification of human papillomavirus types associated with cervical cancer. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ, N Engl J Med 2003 348 518 527 10.1056/NEJMoa021641 12571259 (Pubitemid 36159887)
7. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Lancet Oncol 2010 11 1048 1056 10.1016/S1470-2045(10)70230-8 20952254
8. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH, Jama 1994 271 1866 1869 10.1001/jama.1994.03510470070037 8196145 (Pubitemid 24169702)
9. Detection of cervical intraepithelial neoplasia in developing countries. Kitchener HC, Symonds P, Lancet 1999 353 856 857 10.1016/S0140-6736(98)00417-6 10093972 (Pubitemid 29126867)
10. Cancer Incidence and Survival Report: Saudi Arabia 2007. SCR Report 2007, Special Edition. Saudi Cancer Registry Riyadh, Kingdom of Saudi Arabia: Ministry of Health 2011 (URL: http://www.scr.org.sa)
11. The pattern of malignancies in Karachi (1995 to 1996). Bhurgri Y, Bhurgri A, Rahim A, Bhutto K, Pinjani PK, Usman A, Hasan SH, J Pak Med Assoc 1999 49 157 161 10599201
12. Pattern of cervical smear cytology in western region of Saudi Arabia. Altaf F, Ann Saudi Med 2001 21 94 96 (Pubitemid 33094736)
13. Profile of Pap smear cytology in the Western region of Saudi Arabia. Jamal A, Al-Maghrabi JA, Saudi Med J 2003 24 1225 1229 14647558 (Pubitemid 37527326)
14. Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan. Raza SA, Franceschi S, Pallardy S, Malik FR, Avan BI, Zafar A, Ali SH, Pervez S, Serajuddaula S, Snijders PJ, Br J Cancer 2010 102 1657 1660 10.1038/sj.bjc.6605664 20407442
15. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, N Engl J Med 2002 346 1105 1112 10.1056/NEJMoa011688 11948269 (Pubitemid 34984600)
16. Human papillomavirus infection in a population-based sample of women in Algiers, Algeria. Hammouda D, Clifford GM, Pallardy S, Ayyach G, Chekiri A, Boudrich A, Snijders PJ, van Kemenade FJ, Meijer CJ, Bouhadef A, Int J Cancer 2011 128 2224 2229 10.1002/ijc.25539 20607828
17. Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia. Alsbeih G, Ahmed R, Al-Harbi N, Venturina LA, Tulbah A, Balaraj K, Gynecol Oncol 2011 121 522 526 10.1016/j.ygyno.2011.01.033 21353296
18. Detection and genotyping of human papilloma virus in cervical cancer specimens from Saudi patients. Al-Badawi IA, Al-Suwaine A, Al-Aker M, Asaad L, Alaidan A, Tulbah A, Fe Bohol M, Munkarah AR, Int J Gynecol Cancer 2011 21 907 910 10.1097/IGC.0b013e318214219f 21697680
19. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women-Analyses of national data and systematic review of the literature. Khorasanizadeh F, Hassanloo J, Khaksar N, Taheri SM, Marzaban M, Rashidi BH, Sari AA, Zendehdel K, Gynecol Oncol 2012 128 277 281 23200918
20. Human papillomavirus infection among young adolescents in India: impact of vaccination. Hussain S, Bharadwaj M, Nasare V, Kumari M, Sharma S, Hedau S, Das BC, J Med Virol 2012 84 298 305 10.1002/jmv.22261 22170551
21. Human papilloma virus-16/18 cervical infection among women attending a family medical clinic in Riyadh. Al-Muammar T, Al-Ahdal MN, Hassan A, Kessie G, Dela Cruz DM, Mohamed GE, Ann Saudi Med 2007 27 1 5 10.4103/0256-4947.51540 17277496 (Pubitemid 46579111)
22. Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India. Duttagupta C, Sengupta S, Roy M, Sengupta D, Bhattacharya P, Laikangbam P, Roy S, Ghosh S, Das R, Int J Gynecol Cancer 2004 14 293 303 10.1111/j.1048-891X.2004.014213.x 15086729 (Pubitemid 38533901)
23. Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia. de Boer MA, Vet JN, Aziz MF, Cornain S, Purwoto G, van den Akker BE, Dijkman A, Peters AA, Fleuren GJ, Int J Gynecol Cancer 2006 16 1809 1814 10.1111/j.1525-1438.2006.00701.x 17009976 (Pubitemid 44470040)
24. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L, Nature 1998 393 229 234 10.1038/30400 9607760 (Pubitemid 28261713)
25. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. Makni H, Franco EL, Kaiano J, Villa LL, Labrecque S, Dudley R, Storey A, Matlashewski G, Int J Cancer 2000 87 528 533 10.1002/1097-0215(20000815)87:4<528::AID-IJC11>3.0. CO;2-O 10918193 (Pubitemid 30639812)
26. TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das BR, Del Mistro A, Dybikowska A, Lancet Oncol 2009 10 772 784 10.1016/S1470-2045(09)70187-1 19625214
27. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Cell 2004 119 591 602 10.1016/j.cell.2004.11.022 15550242 (Pubitemid 39535748)
28. Involvement of single-nucleotide polymorphisms in predisposition to head and neck cancer in Saudi Arabia. Al-Hadyan KS, Al-Harbi NM, Al-Qahtani SS, Alsbeih GA, Genet Test Mol Biomarkers 2012 16 95 101 10.1089/gtmb.2011.0126 21877955
29. TP53, MDM2, NQO1, and susceptibility to cervical cancer. Hu X, Zhang Z, Ma D, Huettner PC, Massad LS, Nguyen L, Borecki I, Rader JS, Cancer Epidemiol Biomarkers Prev 2010 19 755 761 10.1158/1055-9965.EPI-09-0886 20200430
30. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), Human Papilomavirus and Related Cancers in the World Summary Report 2010 Available at:: http://www.who.int/hpvcentre. Accessed 2012
31. Burden of human papillomavirus-related cervical disease in the extended middle East and north Africa-a comprehensive literature review. Seoud M, J Low Genit Tract Dis 2012 16 106 120 10.1097/LGT.0b013e31823a0108 22371041
32. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S, J Infect Dis 2010 202 1789 1799 10.1086/657321 21067372
33. HPV genotype distribution according to severity of cervical neoplasia. Sjoeborg KD, Trope A, Lie AK, Jonassen CM, Steinbakk M, Hansen M, Jacobsen MB, Cuschieri K, Eskild A, Gynecol Oncol 2010 118 29 34 10.1016/j.ygyno.2010.03.007 20406711
34. Correlation between the presence of high-risk human papillomaviruses and Id gene expression in Syrian women with cervical cancer. Darnel AD, Wang D, Ghabreau L, Yasmeen A, Sami S, Akil N, Al Moustafa AE, Clin Microbiol Infect 2010 16 262 266 10.1111/j.1469-0691.2009.02774.x 19438642
35. XRCC1 is required for DNA single-strand break repair in human cells. Brem R, Hall J, Nucleic Acids Res 2005 33 2512 2520 10.1093/nar/gki543 15867196 (Pubitemid 41511270)
36. Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Taylor RM, Thistlethwaite A, Caldecott KW, Mol Cell Biol 2002 22 2556 2563 10.1128/MCB.22.8.2556-2563.2002 11909950 (Pubitemid 34262978)
37. The XRCC1-77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Brem R, Cox DG, Chapot B, Moullan N, Romestaing P, Gerard JP, Pisani P, Hall J, Carcinogenesis 2006 27 2469 2474 10.1093/carcin/bgl114 16829685 (Pubitemid 44884105)
38. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis. Li Y, Liu F, Tan SQ, Wang Y, Li SW, PLoS One 2012 7 44441 10.1371/journal.pone.0044441 22984511
39. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Koushik A, Platt RW, Franco EL, Cancer Epidemiol Biomarkers Prev 2004 13 11 22 10.1158/1055-9965.EPI-083-3 14744727 (Pubitemid 38116615)
40. Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Sousa H, Santos AM, Pinto D, Medeiros R, Int J Mol Med 2007 20 731 741 17912468
41. Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis. Jee SH, Won SY, Yun JE, Lee JE, Park JS, Ji SS, Int J Gynaecol Obstet 2004 85 301 308 10.1016/j.ijgo.2003.08.017 15145278 (Pubitemid 38622573)